These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33182767)
1. Stimuli-Responsive Micelles with Detachable Poly(2-ethyl-2-oxazoline) Shell Based on Amphiphilic Polyurethane for Improved Intracellular Delivery of Doxorubicin. Xu K; Liu X; Bu L; Zhang H; Zhu C; Li Y Polymers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182767 [TBL] [Abstract][Full Text] [Related]
2. pH and reduction dual-responsive micelles based on novel polyurethanes with detachable poly(2-ethyl-2-oxazoline) shell for controlled release of doxorubicin. Bu L; Zhang H; Xu K; Du B; Zhu C; Li Y Drug Deliv; 2019 Dec; 26(1):300-308. PubMed ID: 30895837 [TBL] [Abstract][Full Text] [Related]
3. Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood-brain barrier and enhance doxorubicin antiglioma effect. Li Y; Baiyang L; Leran B; Zhen W; Yandong X; Baixiang D; Dandan Z; Yufu Z; Jun L; Rutong Y; Hongmei L Drug Deliv; 2017 Nov; 24(1):1782-1790. PubMed ID: 29172749 [TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery. Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909 [TBL] [Abstract][Full Text] [Related]
5. Poly(ethylene glycol)-sheddable reduction-sensitive polyurethane micelles for triggered intracellular drug delivery for osteosarcoma treatment. Yang Z; Guo Q; Cai Y; Zhu X; Zhu C; Li Y; Li B J Orthop Translat; 2020 Mar; 21():57-65. PubMed ID: 32099805 [TBL] [Abstract][Full Text] [Related]
6. Facile Preparation of Reduction-Responsive Micelles Based on Biodegradable Amphiphilic Polyurethane with Disulfide Bonds in the Backbone. Zhang P; Hu J; Bu L; Zhang H; Du B; Zhu C; Li Y Polymers (Basel); 2019 Feb; 11(2):. PubMed ID: 30960245 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable polyurethane micelles with pH and reduction responsive properties for intracellular drug delivery. Guan Y; Su Y; Zhao L; Meng F; Wang Q; Yao Y; Luo J Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1221-1230. PubMed ID: 28415410 [TBL] [Abstract][Full Text] [Related]
8. Reduction responsive and surface charge switchable polyurethane micelles with acid cleavable crosslinks for intracellular drug delivery. Zhao L; Liu C; Qiao Z; Yao Y; Luo J RSC Adv; 2018 May; 8(32):17888-17897. PubMed ID: 35542076 [TBL] [Abstract][Full Text] [Related]
9. The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, pH-sensitivity and endosomal escape. Xu H; Zhang W; Li Y; Ye FF; Yin PP; Yu X; Hu MN; Fu YS; Wang C; Shang de J Pharm Res; 2014 Nov; 31(11):3038-50. PubMed ID: 24805279 [TBL] [Abstract][Full Text] [Related]
10. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging. Xiong D; Zhang X; Peng S; Gu H; Zhang L Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801 [TBL] [Abstract][Full Text] [Related]
11. Shell-sheddable micelles based on dextran-SS-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin. Sun H; Guo B; Li X; Cheng R; Meng F; Liu H; Zhong Z Biomacromolecules; 2010 Apr; 11(4):848-54. PubMed ID: 20205476 [TBL] [Abstract][Full Text] [Related]
12. Effects of the molecular weight and molar ratio of poly(2-ethyl-2-oxazoline)-based lipid on the pH sensitivity, stability, and antitumor efficacy of liposomes. Wen L; Huang S; Du W; Zhu C; Xu H Drug Dev Ind Pharm; 2020 Feb; 46(2):283-295. PubMed ID: 31944130 [TBL] [Abstract][Full Text] [Related]
13. Bioreducible poly(2-ethyl-2-oxazoline)-PLA-PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin. Gaspar VM; Baril P; Costa EC; de Melo-Diogo D; Foucher F; Queiroz JA; Sousa F; Pichon C; Correia IJ J Control Release; 2015 Sep; 213():175-191. PubMed ID: 26184050 [TBL] [Abstract][Full Text] [Related]
14. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838 [TBL] [Abstract][Full Text] [Related]
15. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy. Yu S; Ding J; He C; Cao Y; Xu W; Chen X Adv Healthc Mater; 2014 May; 3(5):752-60. PubMed ID: 24574261 [TBL] [Abstract][Full Text] [Related]
16. Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. Cheon Lee S; Kim C; Chan Kwon I; Chung H; Young Jeong S J Control Release; 2003 May; 89(3):437-46. PubMed ID: 12737846 [TBL] [Abstract][Full Text] [Related]
17. One-pot synthesis of crosslinked amphiphilic polycarbonates as stable but reduction-sensitive carriers for doxorubicin delivery. Yi X; Zhang Q; Dong H; Zhao D; Xu JQ; Zhuo R; Li F Nanotechnology; 2015 Oct; 26(39):395602. PubMed ID: 26357961 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of amphiphilic copolymers containing zwitterionic sulfobetaine as pH and redox responsive drug carriers. Cai M; Leng M; Lu A; He L; Xie X; Huang L; Ma Y; Cao J; Chen Y; Luo X Colloids Surf B Biointerfaces; 2015 Feb; 126():1-9. PubMed ID: 25531063 [TBL] [Abstract][Full Text] [Related]
19. pH/redox dual stimuli-responsive sheddable nanodaisies for efficient intracellular tumour-triggered drug delivery. John JV; Uthaman S; Augustine R; Chen H; Park IK; Kim I J Mater Chem B; 2017 Jul; 5(25):5027-5036. PubMed ID: 32264019 [TBL] [Abstract][Full Text] [Related]
20. Environmental-sensitive micelles based on poly(2-ethyl-2-oxazoline)-b-poly(L-lactide) diblock copolymer for application in drug delivery. Hsiue GH; Wang CH; Lo CL; Wang CH; Li JP; Yang JL Int J Pharm; 2006 Jul; 317(1):69-75. PubMed ID: 16616820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]